Clinical Trials Directory

Trials / Conditions / Spinal and Bulbar Muscular Atrophy

Spinal and Bulbar Muscular Atrophy

9 registered clinical trials studyying Spinal and Bulbar Muscular Atrophy — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingClinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
NCT06862596
Masahisa KatsunoPhase 2 / Phase 3
RecruitingA Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
NCT06169046
Gianni SoraruPhase 2
CompletedA Study of NIDO-361 in Patients With SBMA
NCT06411912
Nido Biosciences, Inc.Phase 2
CompletedA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
NCT05517603
AnnJi Pharmaceutical Co., Ltd.Phase 1 / Phase 2
RecruitingClinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
NCT04944940
National Institute of Neurological Disorders and Stroke (NINDS)—
RecruitingSpecified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bu
NCT03555578
Takeda—
CompletedHigh Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy
NCT02156141
Karen Brorup Heje PedersenN/A
CompletedSafety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy
NCT02024932
Novartis PharmaceuticalsPhase 2
CompletedDutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
NCT00303446
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2